PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
Kelly L. Barton(Duke University), Oren J. Becher(Duke University Hospital)
Cited by 163
Related Papers
Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
|PLoS ONE|2017|186
Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of<i>Hoxa</i>cluster genes and promotion of neuronal lineage
|Neuro-Oncology Advances|2023|4
Effects of Combination Therapy of a CDK4/6 and MEK Inhibitor in Diffuse Midline Glioma Preclinical Models
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1
Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma
|Acta Neuropathologica Communications|2014|0